Concepedia

William F. Vernier

WF

Statistics

Publications

16

Citations

1.5K

H-Index

16

Active since

2000

Affiliations

Pfizer (United States)(Current)

Dart NeuroScience (United States)

Scripps Institution of Oceanography

University of Missouri–St. Louis

Scripps (United States)

William F. Vernier is an author at Pfizer (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2000–2020

16

Publications

16

Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic

Emily N. Chin, Chenguang Yu, Vincent F. Vartabedian et al. · Science · 2020 · 521 citations

, , +17

Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)

David R. Anderson, Shridhar G. Hegde, Emily J. Reinhard et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 265 citations · Full text

, , +10

Pyrrolopyridine Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2)

David R. Anderson, Marvin J. Meyers, William F. Vernier et al. · Journal of Medicinal Chemistry · 2007 · 170 citations · Full text

, , +17

Novel tetrahydro-β-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)

John I. Trujillo, Marvin J. Meyers, David R. Anderson et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 137 citations · Full text

, , +11

Design and Synthesis of Novel and Selective Phosphodiesterase 2 (PDE2a) Inhibitors for the Treatment of Memory Disorders

Laurent Gomez, Mark E. Massari, Troy Vickers et al. · Journal of Medicinal Chemistry · 2017 · 53 citations · Full text

, , +17

1–5 of 16